Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: Germany NLM ID: 8806653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2218 (Electronic) Linking ISSN: 09302794 NLM ISO Abbreviation: Surg Endosc Subsets: MEDLINE
    • Publication Information:
      Publication: 1992- : New York : Springer
      Original Publication: [Berlin] : Springer International, c1987-
    • Subject Terms:
    • Abstract:
      Introduction: Despite the high prevalence of typical symptoms of gastroesophageal reflux disease (GERD), approximately 30% of patients have functional esophageal disorders (FED) on ambulatory reflux monitoring, which may include reflux hypersensitivity (RH; defined as physiologic acid exposure but temporally correlated symptoms of reflux), or functional heartburn (FH; defined as physiologic acid exposure and negative symptom correlation). There are limited epidemiological data characterizing these conditions. We investigated demographic and socioeconomic factors as well as medical comorbidities which may predispose to FED versus pathologic GERD.
      Methods: Adult patients with reflux symptoms for at least 3 months were studied with 24-h pH-impedance testing from 11/2019 to 3/2021. Participants were categorized into pathologic GERD, FH, or RH using pH-impedance data and reported symptom correlation. Demographic data, including age, gender, race/ethnicity, zip code, insurance status, and medical comorbidity data were retrospectively retrieved from the electronic medical record on all participants.
      Results: 229 patients were included. Non-Hispanic Asian ethnicity (OR 5.65; p = 0.01), underweight BMI (OR 7.33; p = 0.06), chronic pain (OR 2.33; p < 0.01), insomnia (OR 2.83; p = 0.06), and allergic rhinitis (OR 3.90; p < 0.01) were associated with a greater risk for FED. Overweight BMI (OR 0.48; p = 0.03) and alcohol use (OR 0.57; p = 0.06) were associated with a decreased risk for FED.
      Discussion: This is the first report of a greater risk of FED in patients with underweight BMI, insomnia, chronic pain, allergic rhinitis, or of Asian or Hispanic ethnicities. The weak associations between female gender and anxiety are corroborated in other studies. Our findings enable clinicians to better screen patients with reflux for this disorder.
      (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
    • Comments:
      Erratum in: Surg Endosc. 2024 May;38(5):2914. doi: 10.1007/s00464-024-10846-3. (PMID: 38619560)
    • References:
      Spechler SJ (1992) Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 51:24–29. (PMID: 10.1159/0002009111397743)
      Lind T, Havelund T, Carlsson R et al (1997) Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 32:974–979. (PMID: 10.3109/003655297090112129361168)
      Jones RH, Hungin AP, Phillips J et al (1995) Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1:149–154. (PMID: 10.3109/13814789509161628)
      Patel A, Sayuk GS, Gyawali CP (2016) Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring. J Neurogastroenterol Motil 28:1382–1390. (PMID: 10.1111/nmo.12838)
      Bate CM, Griffin SM, Keeling PW et al (1996) Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 10:547–555. (PMID: 10.1046/j.1365-2036.1996.44186000.x8853758)
      Richter JE, Kovacs TO, Greski-Rose PA et al (1999) Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 13:795–804. (PMID: 10.1046/j.1365-2036.1999.00558.x10383510)
      Martinez SD, Malagon IB, Garewal HS et al (2003) Non-erosive reflux disease (NERD)—acid reflux and symptom patterns. Aliment Pharmacol Ther 17:537–545. (PMID: 10.1046/j.1365-2036.2003.01423.x12622762)
      Yamasaki T, Fass R (2017) Reflux hypersensitivity: a new functional esophageal disorder. J Neurogastroenterol Motil 23:495. (PMID: 10.5056/jnm17097289926735628981)
      Savarino E, Zentilin P, Tutuian R et al (2012) Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol 47:159–168. (PMID: 10.1007/s00535-011-0480-022038553)
      Roman S, Gyawali CP, Savarino E et al (2017) Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. J Neurogastroenterol Motil 29:1–5. (PMID: 10.1111/nmo.13067)
      de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, Tolone S, Scagliarini M, Bellini M, Marabotto E, Furnari M et al (2016) Functional heartburn overlaps with irritable bowel syndrome more often than GERD. Am J Gastroenterol 111:1711–1717. (PMID: 10.1038/ajg.2016.43227644732)
      Gyawali CP, Kahrilas PJ, Savarino E et al (2018) Modern diagnosis of GERD: the Lyon Consensus. Gut 67:1351–1362. (PMID: 10.1136/gutjnl-2017-31472229437910)
      Savarino E, Bredenoord AJ, Fox M et al (2017) Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol 14:665–676. (PMID: 10.1038/nrgastro.2017.13028951582)
      Lam H, Breumelhof R, Roelofs JM et al (1994) What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci 39:402–409. (PMID: 10.1007/BF020902158313825)
      Herregods TV, Pauwels A, Tack J et al (2017) Reflux-cough syndrome: assessment of temporal association between reflux episodes and cough bursts. J Neurogastroenterol Motil 29:e13129. (PMID: 10.1111/nmo.13129)
      Wiener GJ, Richter JE, Copper JB et al (1988) The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 83(4):358–361.
      Weusten BL, Roelofs JM, Akkermans LM et al (1994) The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 107:1741–1745. (PMID: 10.1016/0016-5085(94)90815-X7958686)
      Ghillebert G, Janssens J, Vantrappen G et al (1990) Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 31:738–744. (PMID: 10.1136/gut.31.7.73823700091378526)
      United States Census Bureau (2019) American Community Survey 1-year estimates, table S1903 (2005–2019). https://data.census.gov/.
      United States Census Bureau (2014) American Community Survey 5-year estimates (2010–2014). https://data.census.gov/.
      Jacobson BC, Somers SC, Fuchs CS et al (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354:2340–2348. (PMID: 10.1056/NEJMoa054391167382702782772)
      Savarino E et al (2011) Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis 43:940–945. (PMID: 10.1016/j.dld.2011.07.01421944835)
      Berstad AR, Weberg R, Larsen IF et al (1986) Relationship of hiatus hernia to reflux oesophagitis a prospective study of coincidence, using endoscopy. Scand J Gastroenterol 21:55–58. (PMID: 10.3109/003655286090346223952452)
      Mayer EM, Grabowski CJ, Fisher RS (1978) Effect of graded doses of alcohol upon esophageal motor function. Gastroenterology 76:1133–1136. (PMID: 10.1016/0016-5085(78)90088-4)
      Barlow WJ, Orlando RC (2005) The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 128:771–778. (PMID: 10.1053/j.gastro.2004.08.01415765412)
      Bouchoucha M, Mary F, Bon C et al (2018) Sleep quality and functional gastrointestinal disorders. A psychological issue. J Dig Dis 19:84–92. (PMID: 10.1111/1751-2980.1257729316246)
      Vakil N, Wernersson B, Wissmar J et al (2016) Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia. United Eur Gastroenterol J 4:191–198. (PMID: 10.1177/2050640615599716)
      Jones MP, Walker MM, Ford AC et al (2014) The overlap of atopy and functional gastrointestinal disorders among 23 471 patients in primary care. Aliment Pharmacol Ther 40:382–391. (PMID: 10.1111/apt.1284624961872)
      Schnedl WJ, Enko D (2021) Considering histamine in functional gastrointestinal disorders. Crit Rev Food Sci Nutr 61:2960–2967. (PMID: 10.1080/10408398.2020.179104932643952)
      Wouters MM, Vicario M, Santos J (2016) The role of mast cells in functional GI disorders. Gut 65:155–168. (PMID: 10.1136/gutjnl-2015-30915126194403)
      Dickman R, Maradey-Romero C, Fass R (2014) The role of pain modulators in esophageal disorders—no pain no gain. Neurogastroenterol Motil 26:603–610. (PMID: 10.1111/nmo.1233924750261)
      Avidan B, Sonnenberg A, Giblovich H, Sontag SJ (2001) Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther 15:1907–1912. (PMID: 10.1046/j.1365-2036.2001.01131.x11736721)
      Campos GM, Peters JH, DeMeester TR et al (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3(3):292–300. (PMID: 10.1016/S1091-255X(99)80071-710481122)
    • Contributed Indexing:
      Keywords: Ambulatory pH monitoring; Functional esophageal disorder; Gastroesophageal reflux disease; Impedance testing; Reflux hypersensitivity
    • Publication Date:
      Date Created: 20240326 Date Completed: 20240508 Latest Revision: 20240731
    • Publication Date:
      20240801
    • Accession Number:
      10.1007/s00464-024-10714-0
    • Accession Number:
      38528263